Skip to main content
European Commission logo print header

Sorting of Self

Project description

Shedding light on the immune puzzle

Our understanding of the processes that facilitate the efficient removal of self-antigens from apoptotic and necrotic cells, which allows the immune system to effectively respond to invading pathogens, is currently limited. The lack of suitable techniques has hindered the identification and tracking of specific phagocyte subsets responsible for simultaneously clearing dying cells and pathogens within a living organism. To address these limitations, the ERC-funded SOS project aims to develop groundbreaking tools that will shed light on the intricate mechanisms involved in the clearance of dying cells and pathogens, particularly in the presence of inflammation. The project seeks to enhance our knowledge of the underlying causes of autoimmune and infectious diseases, and to foster the development of innovative therapeutic approaches.

Objective

During inflammation and infection, we are simultaneously confronted with both self and non-self in form of dying cells and microbes, respectively. Mechanisms that facilitate the non-immunogenic clearance of self-antigens derived from apoptotic and necrotic cells and that, in parallel, allow the initiation of an immune response against invading pathogens are incompletely understood.
Recent data from our laboratory show that the immune system actively sorts apoptotic cells (ACs) and bacteria into distinct subspecies of macrophages and dendritic cells thereby enabling a segregated processing of self and non-self as well as a differential immune response against these two entities. Incorrect sorting and aberrant uptake of AC-derived self-antigens by pro-inflammatory and antigen-presenting dendritic cells, however, results in the break of self-tolerance and autoimmunity.
Due to technical limitations, the identification and fate-mapping of specific phagocyte subsets that mediate the simultaneous clearance of dying cells and pathogens in vivo has remained largely elusive. We thus plan to develop novel tools that are based on cutting-edge technologies to comprehensively elucidate the sorting of dying cells and pathogens under inflammatory conditions in vivo. We plan to generate TAT-Cre transgenic mice and bacteria that will be used in conjunction with R26-eYFP reporter animals to permanently track phagocytes after ingestion of endogenously accumulated dying cells and pathogens, respectively. These approaches will enable us to characterize the involved phagocytes, study molecular mechanisms underlying the differential processing of self and non-self and follow the phagocyte’s migratory behaviour and its subsequent differentiation. The obtained data will not only provide insights into the pathogenesis of autoimmune and infectious diseases, but will also foster the development of novel therapeutic strategies for the treatment of such disorders.

æ

Coordinator

UNIVERSITATSKLINIKUM ERLANGEN
Net EU contribution
€ 1 479 781,00
Address
Maximiliansplatz 2
91054 Erlangen
Germany

See on map

Region
Bayern Mittelfranken Erlangen, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Other funding
€ 0,00

Beneficiaries (1)